The organisation - The Stichting Katholieke Universiteit (RUNMC) is one of the leading academic communities in the Netherlands. With nearly 9,000 employees and 3,000 students, RUNMC combines patient care, research and education/training. A prominent part of the RUNMC is the Nijmegen Institute for Molecular Life Sciences (NCMLS), which is a recognised international research school offering a stimulating environment for scientists of all levels and aims to generate basic knowledge from molecular medical research and translate this knowledge into clinical application through disease diagnostics development and innovation in the treatment of patients.

Dr William Leenders is an Associate Professor and heads the 'targeting group' of the department of Pathology. Targeting of neovasculature is his main research line. Dr Leenders is a chemist with an extensive experience in molecular biology and is heavily involved in technology development and target finding, making use of phage display technology and llama heavy chain-only antibodies (VHH).